24-Norursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammation

[1]  T. Karonitsch,et al.  The immunobiology of mTOR in autoimmunity. , 2019, Journal of autoimmunity.

[2]  Keiryn L. Bennett,et al.  Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function , 2019, Immunity.

[3]  M. Altfeld,et al.  Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice. , 2019, Journal of hepatology.

[4]  Alexander Lercher,et al.  CD8+ T cells induce cachexia during chronic viral infection , 2019, Nature Immunology.

[5]  H. Pircher,et al.  Enhancing immunity prevents virus‐induced T‐cell‐mediated immunopathology in B cell‐deficient mice , 2019, European journal of immunology.

[6]  T. Karlsen,et al.  Primary sclerosing cholangitis - a comprehensive review. , 2017, Journal of hepatology.

[7]  J. Neuberger,et al.  Twenty‐Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  M. Manns,et al.  norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis. , 2017, Journal of hepatology.

[9]  Haiyan Tan,et al.  Integrative Proteomics and Phosphoproteomics Profiling Reveals Dynamic Signaling Networks and Bioenergetics Pathways Underlying T Cell Activation , 2017, Immunity.

[10]  David M. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[11]  E. Wherry,et al.  Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion. , 2016, Immunity.

[12]  M. Feuerer,et al.  Re-examining the Nature and Function of Self-Reactive T cells. , 2016, Trends in immunology.

[13]  Greg M. Delgoffe,et al.  mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation. , 2015, The Journal of clinical investigation.

[14]  M. Trauner,et al.  New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. , 2015, Journal of hepatology.

[15]  G. Reynolds,et al.  Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. , 2014, Gastroenterology.

[16]  H. Dienes,et al.  Clonal Exhaustion as a Mechanism to Protect Against Severe Immunopathology and Death from an Overwhelming CD8 T Cell Response , 2013, Front. Immunol..

[17]  Chih-Hao Chang,et al.  Fueling Immunity: Insights into Metabolism and Lymphocyte Function , 2013, Science.

[18]  David K. Finlay,et al.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells , 2012, The Journal of experimental medicine.

[19]  G. V. D. Windt,et al.  Metabolic switching and fuel choice during T‐cell differentiation and memory development , 2012, Immunological reviews.

[20]  Mee-Sup Yoon,et al.  Phosphatidic Acid Activates Mammalian Target of Rapamycin Complex 1 (mTORC1) Kinase by Displacing FK506 Binding Protein 38 (FKBP38) and Exerting an Allosteric Effect* , 2011, The Journal of Biological Chemistry.

[21]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[22]  A. Thomson,et al.  Immunoregulatory functions of mTOR inhibition , 2009, Nature Reviews Immunology.

[23]  K. Zatloukal,et al.  24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2006, Gastroenterology.

[24]  P. Olinga,et al.  Novel biotransformation and physiological properties of norursodeoxycholic acid in humans , 2005, Hepatology.

[25]  H. Tilg,et al.  Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2004, Gastroenterology.

[26]  D. Wodarz,et al.  Persistent Virus Infection despite Chronic Cytotoxic T-Lymphocyte Activation in Gamma Interferon-Deficient Mice Infected with Lymphocytic Choriomeningitis Virus , 2000, Journal of Virology.

[27]  Antonio Bertoletti,et al.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. , 2000 .

[28]  R. Zinkernagel,et al.  T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I- restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? , 1986, The Journal of experimental medicine.

[29]  J. Steinbach,et al.  Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents. , 1986, Gastroenterology.

[30]  K. Zatloukal,et al.  Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice , 2009, Hepatology.